What does AMERISAFE do?
AMERISAFE, Inc. is a Nasdaq-listed specialty insurer focused almost entirely on workers’ compensation for small and midsized employers in hazardous occupations. The company operates through insurance subsidiaries including American Interstate Insurance Company, American Interstate Insurance Company of Texas and Silver Oak Casualty. Its narrow mandate matters: rather than spreading underwriting resources across personal auto, homeowners and many commercial lines, AMERISAFE concentrates on workplace injury risk where safety inspection, payroll auditing, medical case management and claims reserving determine economics.
Which customers and industries define the company?
The target customer often has a modest corporate footprint but a severe occupational-risk profile. AMERISAFE’s official company description highlights construction and trucking, while its industry pages also cover agribusiness, manufacturing, marine, oil and gas, and wood products. These are payroll-heavy operations where falls, vehicle accidents, machinery injuries and long-duration medical claims can create large losses.
How does AMERISAFE make money?
AMERISAFE earns underwriting income when premiums exceed claims, claim-adjustment costs, commissions, operating expenses and policyholder dividends. It also earns investment income while holding premiums before claims are paid. Workers’ compensation policies are generally priced as a rate per $100 of insured payroll, so premium volume reflects three moving parts: policy count, customer payroll and approved rates. Final payroll audits can increase or decrease premium after the policy period.
Why is underwriting discipline more important than simple premium growth?
A new policy can add revenue immediately but destroy value for years if its rate is inadequate for future medical severity. AMERISAFE therefore emphasizes selective underwriting, field safety and personalized claims handling. The company’s safety-service model places professionals near policyholders, while its claims process is designed for early intervention and lower case-manager workloads.
Which revenue source matters most?
Net premiums earned are the dominant recurring revenue source. Q1 2026 net premiums earned were $75.1 million versus $6.6 million of net investment income. Investment income is economically meaningful, but AMERISAFE’s long-run quality still depends on pricing policies correctly and resolving claims below the amount embedded in premiums.
What does AMERISAFE’s latest quarter show?
The most recent reported package covers the quarter ended March 31, 2026. The Q1 2026 earnings release reported 8.2% growth in voluntary premiums on policies written. The filed March 2026 Form 10-Q shows that premium growth continued, but claim costs and the combined ratio also moved higher.
| Q1 metric | 2026 | 2025 | Interpretation |
|---|---|---|---|
| Gross premiums written | $88.5M | $83.8M | New-business and in-force growth outweighed lower audit adjustments. |
| Net premiums written | $84.4M | $79.6M | Ceded premiums were 5.1% of gross earned premium versus 5.7%. |
| Total revenue | $80.1M | $72.6M | Premium growth more than offset weaker equity-market marks. |
| Loss and LAE expense | $46.4M | $40.2M | The 15.6% increase exceeded earned-premium growth. |
| Net combined ratio | 93.2% | 89.1% | Still profitable underwriting, but with 4.1 points of year-over-year pressure. |
| Return on average equity | 13.1% | 13.8% | Annualized profitability softened as net income declined. |
What changed beneath the headline?
Management set the initial 2026 accident-year loss and LAE ratio at 72.0%, compared with an initial 71.0% estimate for 2025. The filing attributes the higher assumption to continuing rate decreases, long-term frequency and severity trends, and medical inflation. Favorable development on older accident years still reduced Q1 2026 loss expense by $7.6 million, but that benefit was below the $8.7 million recorded a year earlier.
How profitable was AMERISAFE in 2025?
Full-year 2025 provides the cleaner cycle baseline. According to the official year-end release, gross premiums written rose 6.7% to $313.9 million and net premiums earned rose 4.6% to $283.1 million. Yet net income declined 15.0% to $47.1 million because the net loss ratio increased, investment income fell and favorable reserve development was slightly lower.
| Full-year metric | FY2025 | FY2024 | Why it matters |
|---|---|---|---|
| Gross premiums written | $313.9M | $294.1M | Top-line production returned to growth despite rate pressure. |
| Net premiums earned | $283.1M | $270.6M | Earned revenue followed written premium with a lag. |
| Underwriting profit | $24.6M | $30.6M | Profit remained positive but fell 19.5%. |
| Net investment income | $27.0M | $29.2M | A smaller average investable asset base offset yield improvement. |
| Net income | $47.1M | $55.4M | GAAP profit absorbed weaker underwriting and investment contribution. |
| Diluted EPS | $2.47 | $2.89 | Per-share earnings fell 14.5%. |
| Return on average equity | 18.5% | 20.2% | Still high, partly because capital distributions reduced equity. |
Why do reserve releases deserve careful interpretation?
FY2025 favorable prior-year reserve development was $33.9 million, compared with $34.9 million in FY2024. This reflects claims ultimately costing less than earlier estimates and supports current earnings. It also means reported profitability is not explained only by the newest policy year. Analysts should separate the current accident-year loss ratio of 72.0% from the 12.0-point favorable prior-year development that reduced the reported FY2025 net loss ratio to 60.0%.
Which strategic turning points shaped AMERISAFE?
AMERISAFE’s history is less about serial acquisitions and more about preserving a focused operating system. The company’s official history and culture material stresses long-tenured specialists, consistency and safety. The milestones below matter because each strengthened public-market access, claims discipline or shareholder alignment.
-
1986The business began writing workers’ compensation, establishing the monoline specialization that still defines underwriting and staffing.
-
2005The initial public offering became effective in November, and AMSF began trading on Nasdaq, creating permanent access to public equity and disclosure discipline.
-
2010The board initiated a share-repurchase program, adding buybacks to the company’s later dividend-oriented capital-return model.
-
2022Shareholders approved a 500,000-share equity and incentive plan, formalizing performance-linked retention for executives, employees and directors.
-
2025The board reauthorized a $25.0 million repurchase program while the company returned $2.56 per share through regular and extraordinary dividends.
-
2026The quarterly dividend rose 5.1% to $0.41 per share, and Guillermo A. Ramos was appointed chief financial officer effective May 7, refreshing finance leadership.
What gives AMERISAFE a competitive advantage?
The moat is operational rather than technological. Hazardous workers’ compensation requires accurate class-code selection, field inspection, credible agent relationships, rapid accident reporting, medical coordination and patient reserve management. AMERISAFE employs much of this capability internally, creating a feedback loop from claims outcomes to underwriting decisions. The approach can reduce information gaps that broader carriers face when hazardous classes are only a small part of their portfolio.
How does specialization translate into economics?
The trade-off is clear. Concentration makes the organization better at its chosen problem, but it also exposes shareholders to one insurance cycle. A diversified carrier can offset weak workers’ compensation pricing with other lines; AMERISAFE cannot. Its advantage is therefore durable only if discipline remains stronger than the industry’s temptation to chase premium when rates decline.
Who competes with the company?
Competition changes by state and occupational class. AMERISAFE competes with large multiline insurers, regional specialty carriers, state insurance pools, self-insured employers and self-insurance funds. Employers Holdings is the closest public monoline comparison, while broader specialty peers such as Skyward Specialty, James River and W.R. Berkley overlap in selected commercial markets. The relevant comparison is not simply size; it is willingness to write hazardous classes and the ability to manage severe claims.
| Competitive dimension | AMERISAFE position | Potential rival advantage |
|---|---|---|
| Hazard-class expertise | Deep, long-standing specialization | A specialist can match expertise in selected states or niches. |
| Capital scale | Conservative portfolio and profitable underwriting | National carriers have larger balance sheets and marketing budgets. |
| Agent access | About 1,400 agencies at FY2025 | Multiline carriers can bundle products and deepen agency economics. |
| Claims service | Field case managers and early intervention | Scaled carriers may have broader provider networks and data resources. |
How strong are the balance sheet and capital returns?
Insurance balance-sheet analysis starts with reserves and investable assets, not conventional net debt. At March 31, 2026, total assets were $1.123 billion, loss and LAE reserves were $601.9 million, and shareholders’ equity was $246.6 million. The investment portfolio including cash totaled $773.6 million, providing the asset base that supports claims payments and investment income.
What is inside the investment portfolio?
How is capital being returned?
| Capital item | Period / amount | Interpretation |
|---|---|---|
| Regular dividends | $1.56/share in FY2025 | Recurring distribution before the 2026 increase. |
| Extraordinary dividend | $1.00/share in FY2025 | Returned surplus capital beyond the regular cadence. |
| Quarterly dividend | $0.41/share from Q1 2026 | A 5.1% increase from $0.39. |
| Q1 share repurchases | $4.0M | Reduced shares while premium growth remained positive. |
| Remaining authorization | $12.9M at March 31, 2026 | Provides flexibility but does not obligate future purchases. |
Q1 2026 operating cash flow was negative $2.7 million, reflecting the timing of claim, expense and premium cash movements rather than capital expenditure: property-and-equipment purchases were immaterial. For an insurer, one quarter of operating cash flow is less informative than reserve adequacy, statutory capital, liquidity and the relationship between investment assets and future claim payments.
Who owns AMERISAFE stock, and how is it governed?
AMERISAFE has dispersed institutional ownership rather than founder control. The 2026 proxy statement used 18,703,771 outstanding shares for its beneficial-ownership table. BlackRock was the largest disclosed holder, while insiders as a group held less than 2%. This structure gives outside institutions substantial influence over director elections, compensation and capital allocation, but no single holder has operating control.
| Holder / group | Shares | Economic stake | Why it matters |
|---|---|---|---|
| BlackRock, Inc. | 2,903,797 | 15.5% | Largest disclosed institutional holder; meaningful voting influence. |
| Neuberger Berman Group LLC | 1,851,865 | 9.9% | Second disclosed holder above 5%. |
| G. Janelle Frost, CEO | 129,531 | Less than 1% | Meaningful personal alignment without control. |
| Directors and executive officers | 365,475 | 1.95% | Governance is institutionally influenced rather than insider-dominated. |
| Shares outstanding basis | 18,703,771 | 100.0% | Proxy ownership calculation date: April 16, 2026. |
How do incentives shape management behavior?
The 2025 annual incentive plan explicitly weighted combined ratio and growth in premiums written. That pairing is strategically sensible: premium growth alone can encourage underpricing, while combined ratio alone can encourage excessive conservatism. Long-term awards are primarily performance-based, and the CEO’s 2025 target compensation mixed $815,000 of salary, $652,000 of annual incentive and $896,500 of long-term incentive value.
What opportunities and risks could change AMERISAFE’s outlook?
AMERISAFE’s opportunity is to grow policy count and insured payroll while retaining the specialist economics of a smaller company. Q1 2026 voluntary premium growth suggests the distribution engine is gaining traction. The risk is that competitive rate reductions and medical severity make new premium less profitable than it appears. The central strategic tension is therefore volume versus adequacy.
Where can growth come from?
Which filing risks are most material?
| Risk | Financial transmission | Metric to watch |
|---|---|---|
| Rate declines | Premium per unit of payroll falls while claim severity may keep rising. | Current accident-year loss ratio and renewal pricing. |
| Medical and wage inflation | Higher treatment, indemnity and settlement costs pressure reserves. | Loss and LAE growth versus earned premium growth. |
| Reserve estimation | Long-duration claims can develop adversely years after policy issuance. | Prior-year development by accident year. |
| Industry concentration | Construction, trucking and resource activity affect payroll and claim frequency. | Gross premium growth, payroll audits and policy retention. |
| Investment-market volatility | Rates and equity prices affect unrealized value, income and book value. | Portfolio yield, unrealized losses and book value per share. |
| Reinsurance and state funds | Counterparty or program changes could shift severe-loss obligations back to AMERISAFE. | Ceded-premium ratio, recoverables and large-loss retention. |
Which KPIs matter most for AMERISAFE valuation?
A conventional industrial DCF begins with revenue, EBITDA and capital expenditure. For AMERISAFE, the model should begin with premiums, underwriting ratios, reserve development, investment income and capital distributions. Book value also matters because insurance equity is the capital base supporting underwriting capacity. The company’s 2025 Form 10-K is the core source for building that historical model.
| KPI | Definition | Current signal | Valuation use |
|---|---|---|---|
| Gross premiums written | New and renewed premium before reinsurance | $88.5M, Q1 2026 | Leading indicator for future earned premium. |
| Net combined ratio | Loss, expense and policyholder-dividend ratios combined | 93.2%, Q1 2026 | Primary underwriting-margin assumption. |
| Current accident-year loss ratio | Loss estimate before older-year reserve changes | 72.0%, Q1 2026 | Best indicator of fresh-policy economics. |
| Prior-year development | Change in older accident-year reserve estimates | $7.6M favorable, Q1 2026 | Tests whether reported earnings rely on reserve releases. |
| Investment income | Yield earned on reserves and capital | $6.6M, Q1 2026 | Links portfolio size, duration and rates to earnings. |
| Book value per share | Shareholders’ equity divided by shares outstanding | $13.18, March 31, 2026 | Supports price-to-book and residual-income analysis. |
How should a DCF handle an insurer?
Residual-income or dividend-discount approaches may be more intuitive than enterprise free cash flow because policyholder reserves are operating liabilities and investment assets are integral to the product. Whichever method is used, the terminal assumption should reflect workers’ compensation cyclicality, regulation and the possibility that favorable reserve development normalizes.
What is the key takeaway from AMERISAFE analysis?
AMERISAFE is important because it demonstrates how specialization can create an insurance franchise without scale leadership. The company’s field safety network, internal claims expertise, agency reach and conservative investment portfolio have supported underwriting profits and substantial capital returns. FY2025 produced a 91.3% combined ratio and 18.5% return on average equity, while Q1 2026 delivered healthy premium growth and a still-profitable 93.2% combined ratio.
The tension is that growth is arriving as pricing declines and claim-cost assumptions rise. Q1 loss expense increased faster than earned premium, the initial accident-year loss ratio moved to 72.0%, and open claims increased to 4,141. Favorable development remains valuable, but researchers should not treat older-year reserve releases as an unlimited recurring growth engine.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
